[1]
>1.J, M.; Heckelman, P.; Koch, C.; Roman, K. The Merck Index 14th
Ed.Whitehouse Station, NJ: Merck; , 2006.
[2]
Sweetman, S.C. Martindale: The complete drug reference, 36th ed; Pharmaceutical press, 2011.
[3]
Rang, H.; Dale, M.; Ritter, J.; Moore, P. Churchill Livingstone. J. Pharmacol., 2003, 5, 374.
[4]
Cormie, P.; Nairn, M.; Welsh, J. Guidelines: Control of Pain in Adults with Cancer: Summary of SIGN Guidelines. Br. Med. J., 2008, 337(7678), 1106-1109.
[5]
Hundt, H.; Brown, L.; Clark, E. Determination of cinnarizine in plasma by high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl., 1980, 183(3), 378-382.
[6]
Nitsche, V.; Mascher, H. Rapid high-performance liquid chromatographic assay of cinnarizine in human plasma. J. Chromatogr. B Biomed. Sci. Appl., 1982, 227(2), 521-525.
[7]
Rosseel, M.; Lefebvre, R. Sensitive determination of cinnarizine in human plasma by high performance liquid chromatography and fluorescence detection. Chromatographia, 1993, 36(1), 356-358.
[8]
Nowacka-Krukowska, H.; Rakowska, M.; Neubart, K.; Kobylińska, M. High-performance liquid chromatographic assay for cinnarizine in human plasma. Acta. Pol. Pharm-Dru Res., 2007, 64(5), 407-411.
[9]
Angelov, T. High-performance liquid chromatographic determination of cinnarizine in workplace air. Chromatographia, 2003, 58(7-8), 483-485.
[10]
Heda, A.; Sonawane, A.; Naranje, G.; Puranik, P. A rapid determination of cinnarizine in bulk and pharmaceutical dosage form by LC. J. Chem., 2010, 7(3), 1080-1084.
[11]
Shirode, A.R.; Ghuge, A.D.; Kadam, V.J. HPTLC method development and validation of cinnarizine in bulk and marketed formulation. Int. J. Pharm. Sci. Res., 2016, 7(6), 2416-2422.
[12]
Argekar, A.; Powar, S. Simultaneous HPTLC determination of cinnarizine and domperidone maleate in formulations. J. Planar. Chromat., 1999, 12(4), 272-274.
[13]
Argekar, A.; Shah, S. Simultaneous determination of cinnarizine and domepiridone maleate from tablet dosage form by reverse phase ion pair high performance liquid chromatography. J. Pharm. Biomed. Anal., 1999, 19(6), 813-817.
[14]
Bagade, S.; Walode, S.; Charde, M.; Tajne, M.; Kasture, A. Simultaneous HPTLC estimation of cinnarizine and domperidone in their combined dose tablet. Asian J. Chem., 2005, 17(2), 1116-1126.
[15]
Kumari, S.; Naga, S. Validated RP-HPLC method for simultaneous estimation of Cinnarizine and Domperidone in bulk and pharmaceutical dosage form. J. Pharm. Sci. Innov., 2013, 2(2), 46-50.
[16]
Prahalad, R.; Rao, R.N.; Konam, K.; Edara, S.R.; Rathna, T. Method development and validation for the simultaneous estimation Of domperidone maleate and cinnarizine in a pharmaceutical formulation by RP-HPLC method. Indo. Am. J. Pharm. Res., 2013, 3(10), 8111-8120.
[17]
Kalyankar, T.; Kulkarni, P.; Panchakshari, P.; Narute, A. Simultaneous RP-HPLC estimation of Cinnarizine and Domperidone in Tablet. Res. J. Pharm. Tech., 2014, 7(6), 650-654.
[18]
Chauhan, R.J.; Master, S.M.; Pasha, T.; Thakor, K.A.; Patel, P.U. Development and validation of RP-HPLC method for simultaneous estimation of cinnarizine and paracetamol in their pharmaceutical dosage form. Int. Bull. Drug Res., 2014, 4(7), 41-52.
[19]
Metwally, F.H.; Elzeany, B.; Darwish, H. New methods for determination of cinnarizine in mixture with piracetam by spectrodensitometry, spectrophotometry, and liquid chromatography. J. AOAC Int., 2005, 88(6), 1666-1676.
[20]
El-Houssini, O.M.; Zawilla, N.H.; Mohammad, M.A. Development and validation of RP-LC method for the determination of cinnarizine/piracetam and cinnarizine/heptaminol acefyllinate in presence of cinnarizine reported degradation products. Anal. Chem. Insights, 2013, 8(1), 99-106.
[21]
Navaneethan, G.; Karunakaran, K.; Elango, K. Stability indicating and simultaneous determination of cinnarizine and piracetam from capsule dosage form by reversed phase high performance liquid chromatography. Indian J. Chem. Technol., 2013, 20(9), 323-326.
[22]
SM. E.-A.; MH, H. Exploring novel isocractic HPLC method for quantitative determination of cinnarizine and piracetam in their capsule preparations. J Appl. Pharm., 2016, 8(3), 1-5.
[23]
Khushbu, S.; Pinkal, P. Development and validation of analytical method for simultaneous estimation of cinnarizine and dimenhydrinate in tablet dosage form. Int. J. Pharm. Sci. Res., 2014, 5(11), 4815-4819.
[24]
Lamie, N.T.; Monir, H.H. Simultaneous determination of cinnarizine and dimenhydrinate in binary mixture using chromatographic methods. J. Chromatogr. Sci., 2016, 54(1), 36-42.
[25]
El-Kafrawy, D.S.; Belal, T.S. Validated HPTLC method for the simultaneous determination of cinnarizine and dimenhydrinate in their combined dosage form. J. Associ. Arab Uni. Basic. Appl. Sci., 2016, 19(1), 15-22.
[26]
Ahmed, A.B.; Abdelwahab, N.S.; Abdelrahman, M.M.; Salama, F.M. Simultaneous determination of Dimenhydrinate, Cinnarizine and Cinnarizine impurity by TLC and HPLC chromatographic methods. Bull. Fac. Pharm. Cairo Univ., 2017, 55(1), 163-169.
[27]
Elkady, E.F.; Mahrouse, M.A. Reversed-phase ion-pair HPLC and TLC-densitometric methods for the simultaneous determination of ciprofloxacin hydrochloride and metronidazole in tablets. Chromatographia, 2011, 73(3-4), 297-305.
[28]
Branch, S.K. Guidelines from the international conference on harmonisation; ICH, 2005.
[29]
Convention, U.S.P. USP 32 NF 27: United States Pharmacopeia, National Formulary. Supplement 2. United States Pharmacopeial Convention. 2011.
[30]
G.B.S., Office U.K.S., '”British Pharmacopoeia; Stationery Office: London, 2016.